Eli Lilly Trial Finds Alzheimer’s Drug Can Slow Progress of Disease
Donanemab is not a cure and comes with significant side effects, but patients had longer periods of independent living while on the drug.The drug manufacturer Eli Lilly announced on Wednesday that a clinical trial of an experimental Alzheimer’s drug showed it…